Status:
COMPLETED
Plasma Protein Binding Characteristics of Voriconazole
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Focus of the Study:Protein Binding Characteristics of Voriconazole.
Eligibility:
All Genders
2+ years
Brief Summary
The purpose of this study is to investigate the influence of hypoalbuminemia on the protein binding characteristics of the antifungal drug voriconazole in ICU patients.
Eligibility Criteria
Inclusion
- treated with voriconazole
Exclusion
- None
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01812473
Start Date
February 1 2013
End Date
December 1 2013
Last Update
March 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Leuven
Leuven, Vlaams-Brabant, Belgium, 3000